Brachytherapy of endometrial cancers;Curiethérapie des cancers de l'endomètre

Cancer/Radiotherapie

Volumn 7, Issue 2, 2003, Pages 121-131

  Peiffert, D ^a   Hoffstetter, S ^a   Charra Brunaud, C ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Adenocarcinoma; Brachytherapy; Endometrium; Uterus

Indexed keywords

BEAM THERAPY; BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; DOSIMETRY; ENDOMETRIUM CARCINOMA; FRANCE; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW;

EID: 0038077557     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00018-0     Document Type: Review

References (44)

1. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 1996;60:177-83.
2. Anderson JM, Stea B, Hallum AV, Rogoff E, Childers J. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 2000;46:417-25.
3. Brune D, Couette JE, Lesaunier F, Benabid D. Postoperative vaginal high dose rate brachytherapy(HDRB) in endometrial carcinoma: the experience of Centre François Baclesse 1990-1995 [abstract]. Eur J Cancer 1995;31:S35.
4. Calais G, Vitu L, Descamps P, Body G, Reynaud-Bougnoux A, Lansac J, et al. Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II. Int J Radiat Oncol Biol Phys 1990;19:523-7.
5. Chadha M, Nanavati PJ, Liu P, Fanning J, Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999;75:103-7.
6. Chao CK, Grigsby PW, Perez CA, Mutch DG, Herzog T, Camel HM. Medically inoperable stage I endometrial carcinoma: a few dilemmas in radiotherapeutic management. Int J Radiat Oncol Biol Phys 1996;34:27-31.
7. Charra C, Roy P, Coquard R, Romestaing P, Ardiet JM, Gerard JP. Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1998;40:421-6.
8. Curran WJ, Whittington R, Peters AJ, Fanning J. Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 1988;15:803-8.
9. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997;38:373-80.
10. Fanning J, Nanavati PJ, Hilgers RD. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet Gynecol 1996;87:1041-4.
11. Fishman DA, Roberts KB, Chambers JT, Kohorn EI, Schwartz PE, Chambers SK. Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium. Gynecol Oncol 1996;61:189-96.
12. Graham J. The value of preoperative or postoperative treatment by radium for carcinoma of the uterine body. Surg Gynecol Obstet 1971;132:855-60.
13. Greven KM, D'Agostino RB, Lanciano RM, Corn BW. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Int J Radiat Oncol Biol Phys 1998;42:101-4.
14. Grigsby PW, Perez CA, Kuten A, Simpson JR, Garcia DM, Camel HM, et al. Clinical stage I endometrial cancer: results of adjuvant irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 1991;21:379-85.
15. Horowitz NS, Peters 3rd WA, Smith MR, Drescher CW, Atwood M, Mate TP. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol 2002;99:235-40.
16. Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 1998;70:247-54.
17. Kloetzer KH, Gunther R, Wendt T. [The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy]. Strahlenther Onkol 1997;173:13-7.
18. Kucera H, Knocke TH, Kucera E, Potter R. Treatment of endometrial carcinoma with high dose-rate brachytherapy alone in medically inoperable stage I patients. Acta Obstet Gynecol Scand 1998;77:1008-12.
19. Kupelian PA, Eifel PJ, Tornos C, Burke TW, Delclos L, Oswald MJ. Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys 1993;27:817-24.
20. Lybeert ML, van Putten WL, Ribot JG, Crommelin MA. Endometrial carcinoma: high dose-rate brachytherapy in combination with external irradiation; a multivariate analysis of relapses. Radiother Oncol 1989;16:245-52.
21. MacLeod C, Fowler A. Duval P, D'Costa I, Dalrymple C, Firth I, et al. High dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 1998;42:1033-9.
22. Maingon P, Horiot JC, Fraisse J, Salas S, Collin F, Bone-Lepinoy MC, et al. Preoperative radiotherapy in stage I/II endometrial adenocarcinoma. Radiother Oncol 1996;39:201-8.
23. Mandell R, Nori D, Hilaris B. Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors. Int J Radiat Oncol Biol Phys 1985;11:1103-9.
24. Menegoz F, Cherrie-Challine L. Cancer du corps de l'utérus. In: DgdlS RF, editor. Le cancer en France: incidence et mortalité, situation en 1995, évolution entre 1975 et 1995. Paris: La Documentation Française; 1998. p. 88-93.
25. Morgan 3rd JD, Reddy S, Sarin P, Yordan E, DeGeest K, Hendrickson FR. Isolated vaginal recurrences of endometrial carcinoma. Radiology 1993;189:609-13.
26. Ng TY, Perrin LC, Nicklin JL, Cheuk R, Crandon AJ. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 2000;79:490-4.
27. Nori D, Merimsky O, Batata M, Caputo T. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a long-term follow-up. Int J Radiat Oncol Biol Phys 1994;30:831-7.
28. Onsrud M, Strickert T, Marthinsen AB. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes. Int J Radiat Oncol Biol Phys 2001;49:749-55.
29. Pai HH, Souhami L, Clark BG, Roman T. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. Gynecol Oncol 1997;66:300-7.
30. Pearcey RG, Petereit DG. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol 2000;56:17-22.
31. Peiffert D. La curiethérapie en France en 2000: résultats de l' enquête nationale. Cancer Radiother 2002;6:107-11.
32. Pernot M. Technique de curiethérapie endo-utérine par fils d'iridium 192 (diee « en parapluie ») pour adénocarcinome du corps utérin. J Radiol Electrol 1977;58:395-8.
33. Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer 1999;9:456-62.
34. Piver MS, Yazigi R, Blumenson L, Tsukada Y. A prospective trial comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma. Obstet Gynecol 1979;54:85-9.
35. Poulsen M, Roberts J. The salvage of recurrent endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys 1988;15:809-13.
36. Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys 1990;19:49-54.
37. Roberts J, Brunetto V, Keys H. A phase III randomized study of surgery versus surgery plus adjunctive radiation therapy in intermediate risk endometrial carcinoma (GOG 99) [abstract]. Society of Gynecologic Oncologists, 99th Annual Meeting. 1998. p. 70.
38. Rouanet P, Dubois JB, Gely S, Pourquier H. Exclusive radiation therapy in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993;26:223-8.
39. Shumsky AG, Brasher PM, Stuart GC, Nation JG. Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol 1997;65:379-82.
40. Taghian A, Pernot M, Hoffstetter S, Luporsi E, Bey P. Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1988;15:1135-40.
41. Tewari K, Cappuccini F, Brewster WR, DiSaia PJ, Berman ML, Manetta A, et al. Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. Gynecol Oncol 1999;74:416-22.
42. Touboul E, Belkacemi Y, Buffat L, Deniaud-Alexandre E, Lefranc JP, Lhuillier P, et al. Adénocarcinome de l'endomètre traité par association radiochirurgicale: à propos de 437 cas. Cancer Radiother 2001;5:425-44.
43. Weigensberg IJ. Preoperative radiation therapy in Stage I endometrial adenocarcinoma, II, Final report of a clinical trial. Cancer 1984;53:242-7.
44. Wylie J, Irwin C, Pintilie M, Levin W, Manchul L, Milosevic M, et al. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 2000;77:66-72.